Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep
vein thrombosis [DVT]) and lung (pulmonary embolism [PE]) that sometimes occur within
patients hospitalized for acute medical illness, and to learn how apixaban compares to
enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be
studied.